BMS Archive

Plant · Scientific monograph

Humulus lupulus

Hop

For educational and scientific research only. Not medical advice. Independently verify claims against the cited primary sources. Consult a qualified healthcare professional before using any plant or fungal preparation.

Research areas: Menopause research, Traditional herbal use

Research overview

Historical use

Hop strobiles have traditional use in herbal products, but modern trial results relate to defined extracts [1-3].

Modern research context

A placebo-controlled study reported lower menopause symptom scores with hop tablets, but the abstract omits the preparation, plant part, dose and adverse-event details [1]. Another study tested a standardized extract enriched in 8-prenylnaringenin; results varied by dose and assessment time [3]. A separate sleep study combined hop with valerian and passionflower, so hop effects cannot be isolated [2].

Adverse effects

The trial abstracts do not establish long-term safety or characterize uncommon adverse events [1,2]. Estrogenic activity of some hop constituents requires preparation-specific evaluation [3].

Contraindications

Do not generalize results from one hop extract or a multi-herb sleep product to all hop preparations. Long-term and hormone-sensitive-population safety remain uncertain [1-3].

Clinical and phytochemical data

Used part

Female inflorescences (strobiles) and standardized extracts; clinical products differ in composition [1-3].

Primary active compounds

  • 8-prenylnaringenin is a hop phytoestrogen used to standardize one studied extract; concentrations vary [3].

Mechanism of action

The studies do not establish a clinically validated mechanism for all hop preparations [1-3].

Pharmacokinetics

Absorption

No general human PK profile identified for hop extracts in the cited trials [1-3].

Distribution

Not characterized.

Metabolism

Not characterized.

Excretion

Not characterized.

Safety and interactions

Drug interactions

No broad clinical interaction profile is established; consider that products may have estrogenic constituents, but interaction magnitude is not established [3].

Toxicity

Long-term toxicity and rare harms are not established by the short RCTs [1,2].

Special precautions

Pregnancy

Pregnancy safety for medicinal hop extracts is not established.

Lactation

Lactation safety is not established.

Hepatic impairment

No hepatic impairment-specific evidence identified.

Renal impairment

No renal impairment-specific evidence identified.

Sources and references

  1. [1] Vida Aghamiri et al. The effect of Hop (Humulus lupulus L.) on early menopausal symptoms and hot flashes: A randomized placebo-controlled trial. Complementary Therapies in Clinical Practice. 2016;23:130–135. PMID: 25982391. DOI: 10.1016/j.ctcp.2015.05.001.
  2. [2] Niteeka Maroo, Avijit Hazra, Tapas Das. Efficacy and safety of a polyherbal sedative-hypnotic formulation NSF-3 in primary insomnia in comparison to zolpidem: a randomized controlled trial. Indian Journal of Pharmacology. 2013;45(1):34–39. PMID: 23543804. DOI: 10.4103/0253-7613.106432.
  3. [3] Arne Heyerick et al. A first prospective, randomized, double-blind, placebo-controlled study on the use of a standardized hop extract to alleviate menopausal discomforts. Maturitas. 2006;54(2):164–175. PMID: 16321485. DOI: 10.1016/j.maturitas.2005.10.005.

Additional source links

Continue browsing